Thermo Fisher Scientific (TMO) Net Income - Minority (2020 - 2026)

Thermo Fisher Scientific has disclosed Net Income - Minority across 7 years of filings, most recently posting -$7.0 million for Q1 2026.

• Quarterly Net Income - Minority fell 121.21% year-over-year to -$7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.0 million (down 121.21% YoY) and the FY2025 annual result came in at -$7.0 million, down 121.21% from the prior year.
• Net Income - Minority was little changed at -$7.0 million in Q1 2026, from -$7.0 million in the prior quarter.
• Over five years, Net Income - Minority peaked at $35.0 million in Q2 2025 and troughed at -$62.0 million in Q2 2022.
• A 5-year average of -$13.1 million and a median of -$7.0 million in 2025 frame the typical range for Net Income - Minority.
• Annual changes were most pronounced in 2024 — Net Income - Minority soared 211.11% — and 2025, when it slumped 135.0%.
• Tracing TMO's Net Income - Minority over 5 years: stood at -$54.0 million in 2022, then surged by 120.37% to $11.0 million in 2023, then jumped by 200.0% to $33.0 million in 2024, then tumbled by 121.21% to -$7.0 million in 2025, then changed by 0.0% to -$7.0 million in 2026.
• Business Quant data shows TMO's Net Income - Minority at -$7.0 million in Q1 2026, -$7.0 million in Q4 2025, and -$7.0 million in Q3 2025.